Key terms

About BNGO

Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest BNGO news

Yesterday 8:09am ET Bionano Genomics enters partnership with Diagens Apr 11 8:12am ET Bionano Genomics announces publication showing OGM detects over 1250 variants Apr 05 9:42am ET BioNano Genomics Launches Offering to Bolster Finances Apr 04 1:48pm ET Bionano Genomics sells 8.7M shares at $1.145 in direct offering Apr 03 8:26am ET Bionano Genomics says OGM ‘exclusively detects alterations in known oncogenes’ Apr 02 8:17am ET Bionano Genomics announces 9 poster presentations at AACR meeting Mar 19 8:15am ET Bionano Genomics announces publication of a breast cancer study with OGM Mar 09 11:15am ET BioNano Genomics (BNGO) Gets a Hold from Maxim Group Mar 07 8:20am ET Bionano Genomics announces lineup of content at ACMG Mar 07 1:01am ET A New Cause for Concern: Bionano Genomics Adds a New Share Price & Shareholder Rights Risk Mar 05 4:10pm ET Bionano Genomics sees Q1 revenue $8.25M-$8.75M, consensus $9.69M Mar 05 4:08pm ET Bionano Genomics sees FY24 revenue $37M $41M, consensus $47.17M Mar 05 4:06pm ET Bionano Genomics reports Q4 revenue $10.7M, consensus $10.58M Mar 05 7:05am ET Options Volatility and Implied Earnings Moves Today, March 05, 2024 Feb 28 8:32am ET BioNano Genomics Enhances Capital Structure and Flexibility Feb 28 8:08am ET Bionano Genomics announces amendment to debt financing arrangement Feb 22 8:09am ET Bionano Genomics says ACMG includes OGM in technical laboratory standards Feb 02 7:31am ET Analysts Are Bullish on Top Healthcare Stocks: BioNano Genomics (BNGO), Legend Biotech (LEGN) Jan 30 8:14am ET Bionano Genomics announces conclusion of 2024 Symposium Jan 25 1:35pm ET Maxim Group Remains a Hold on BioNano Genomics (BNGO) Jan 25 8:14am ET Bionano Genomics announces publication of study on OGM Jan 24 8:03am ET Bionano Genomics announces publication of second interim report of trial on OGM Jan 23 8:07am ET Bionano Genomics announces full commercial release of Stratys system Jan 19 8:03am ET Bionano Genomics announces final speaker lineup for 2024 Symposium Jan 19 7:57am ET Bionano Genomics price target lowered to $14 from $24 at Ladenburg

No recent press releases are available for BNGO

BNGO Financials

1-year income & revenue

Key terms

BNGO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

BNGO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms